Although hs-cTnI concentrations were statistically higher in our post-COVID-19 patients with non-ischemic cardiac injury, only two study participants presented with elevated hs-cTnI concentrations, and in fact, in both of them, we found neither active myocarditis nor LGE lesions when using CMR. Here, TNNI3 is linked to COVID-19.